Over the many years since our establishment, we have made an imminent expansion to our infrastructure, creating a comprehensive tertiary care unit that encompasses all fields of medicine. At Royal Care, we only strive to ensure that the benefits of modern healthcare reach all strata of society.
Royal Care Super Specialty Hospital, started functioning as one of the top preferred multi-specialty hospitals in the heart of Coimbatore city for emergencies, primary & speciality care, in virtually all branches of modern medicine. With the commitment to making all facilities at par with the latest advances available to public needs, Royal Care Super Specialty Hospital has become the first in our country to introduce Exablate Neuro for the treatment of Essential Tremors and Tremors caused by Parkinson’s.
We strive to provide a patient-centred culture wherein every patient is attended to with a warm and committed smile. Our unique culture set us apart from the generic hospitals and has been the foundation of our meteoric rise from the constant support of all our patients and their continuing faith in our services.
We aspire to become the dependable destination for people seeking comprehensive healthcare. This has been made possible at large by the meticulous involvement of our Chairman whose vision was to bring together highly talented medical professionals on board with phenomenal expertise in their respective fields. With cutting-edge innovative diagnostic and therapeutic medical technologies, and friendly medical & paramedical staff who provide courteous and compassionate care with a personal approach, at Royal Care Super Specialty Hospitals, our focus is always on the patients and their care.
As pioneers and global leaders in Focused Ultrasound technology, it’s our mission to help transform lives by delivering the therapeutic power of acoustic energy. We strive to turn dependence into independence; discouragement into joy. Today, our physicians are successfully treating tremor-symptoms caused by Essential Tremors and Parkinson’s Disease. We continue to collaborate and innovate, as researchers evaluate our technology in a range of clinical trials.